Institutional Review Board

Purpose

Trinity Health Mid-Atlantic has one Institutional Review Board, established and empowered under the auspices of Trinity Health Mid-Atlantic’s executive authorities, and, if federal funding is used to support human subject research in whole or in part, by the Institution’s Assurance with the federal Office for Human Research Protections.

The primary responsibility of the IRB is to protect the rights and welfare of human subjects in research and to serve as the Privacy Board for the research use and disclosure of Protected Health Information. In doing so, the IRB monitors human subject research to determine that it is conducted ethically and in compliance with federal research regulations, applicable law, HIPAA, Trinity Health Mid-Atlantic’s Assurance, and Trinity Health Mid-Atlantic’s policies and procedures. The IRB fulfills these responsibilities by conducting prospective review of new studies, determining the need for continuing reviews, the informed consent process, procedures used to enroll participants, review of unanticipated problem and adverse event reporting, as well as other functions.

The hospital/healthcare facility locations below use the THMA IRB for regulatory oversight and abide by the IRB and Institutional Policies that are published on this site:

• Holy Cross Germantown Hospital, Germantown, Md.
• Holy Cross Hospital, Silver Spring, Md.
• Mercy Fitzgerald Hospital, Darby, Pa.
• Mercy LIFE West Philadelphia, Philadelphia, Pa.
• Nazareth Hospital, Philadelphia, Pa.
• Saint Francis Hospital, Wilmington, Del.
• St. Mary Medical Center, Langhorne, Pa.